Cargando…
THERAPY OF ENDOCRINE DISEASE: Perspectives on the management of adrenal insufficiency: clinical insights from across Europe
BACKGROUND: Conventional glucocorticoid (GC) replacement for patients with adrenal insufficiency (AI) is inadequate. Patients with AI continue to have increased mortality and morbidity and compromised quality of life despite treatment and monitoring. OBJECTIVES: i) To review current management of AI...
Autores principales: | Grossman, Ashley, Johannsson, Gudmundur, Quinkler, Marcus, Zelissen, Pierre |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioScientifica
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3805018/ https://www.ncbi.nlm.nih.gov/pubmed/24031090 http://dx.doi.org/10.1530/EJE-13-0450 |
Ejemplares similares
-
Prednisolone is associated with a worse lipid profile than hydrocortisone
in patients with adrenal insufficiency
por: Quinkler, Marcus, et al.
Publicado: (2016) -
European Adrenal Insufficiency Registry (EU-AIR): a comparative observational study of glucocorticoid replacement therapy
por: Ekman, Bertil, et al.
Publicado: (2014) -
Editorial: Primary Adrenal Insufficiency - Quality of Life and Long-Term Outcome With Current Treatment Strategies
por: Esposito, Daniela, et al.
Publicado: (2022) -
Characterization of patients with adrenal insufficiency and frequent adrenal crises
por: Quinkler, Marcus, et al.
Publicado: (2021) -
Metabolic Effects of Cortisone Acetate vs Hydrocortisone in Patients With Secondary Adrenal Insufficiency
por: Ekstrand, Elise, et al.
Publicado: (2020)